Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
- Resource Type
- Source
- Subject
10. No inequality 3. Good health - Language
- English